Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Avila Therapeutics describes new BTK inhibitor

Oct. 27, 2011

DelMar Pharmaceuticals commences phase I/II trial of VAL-083

Oct. 26, 2011

FDA grants IND clearance for phase II trial of Aeterna Zentaris' AEZS-108 in breast cancer

Oct. 26, 2011

Bayer's phase III CORRECT trial meets primary endpoint

Oct. 26, 2011

CDC advisory committee recommends Merck & Co.'s HPV vaccine for boys and young men

Oct. 26, 2011

California Stem Cell acquires stem cell therapy program for metastatic melanoma

Oct. 26, 2011

Novel omega-3 MUFAs show oncolytic potential

Oct. 26, 2011

Phase III trial of cabozantinib meets primary endpoint

Oct. 26, 2011

Phase II studies assess NGR-hTNF in lung and ovarian cancer

Oct. 26, 2011

MolMed expands phase III trial of NGR-hTNF

Oct. 25, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...